EGFR anticorps (C-Term)
Aperçu rapide pour EGFR anticorps (C-Term) (ABIN126786)
Antigène
Voir toutes EGFR AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- C-Term
-
Specificité
- This antibody specifically recognizes the C-terminus of EGF receptor (aa 1165 - 1186). Recognition is independent of the phosphorylation status at tyrosine 1173.
-
Attributs du produit
- Synonyms: Epidermal growth factor receptor, EGF Receptor, erbB-1, c-ErbB-1, Receptor tyrosine-proteinkinase erbB-1, Proto-oncogene c-ErbB-1
-
Purification
- Subsequent thiophilic adsorption and size exclusion chromatography
-
Ingrédients
- incl. positive Control
-
Immunogène
- Peptide conjugated to KLH
-
Isotype
- IgG1
-
-
-
-
Indications d'application
-
ELISA (0.05 μg/mL). Western blot. Immunoprecipitation (1-10 μg/mL per 10^6 pervanadate-treated A431 cells). Immunocytochemistry (1-10 μg/mL).
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Reconstitution
- Restore with 1 mL H2O (15 min, RT).
-
Buffer
- PBS, 0.09 % Sodium Azide/PEG and Sucrose
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
-
Store lyophilised product upon arrival at -20 °C. Following reconstitution aliquot and store at 2 - 8 °C for up to three months or freeze inliquid nitrogen at -80 °C for longer. Avoid repeated freezing and thawing. Should this product contain a precipitate, we recommend centrifugation before use.
Shelf life: One year from despatch. -
Date de péremption
- 12 months
-
-
- EGFR (Epidermal Growth Factor Receptor (EGFR))
-
Autre désignation
- EGFR / ERBB1
-
Sujet
- EGFR/erbB receptors are activated upon binding of EGF and EGF-related growth factors such as TGF alpha, beta-cellulin, Hb-EGF, HRG, or NRG. Binding of these ligands leads to receptor homo- and heterodimerization followed by autophosphorylation and activation of downstream signal transduction pathways (MAPK, PI3K/PKB, and STAT). In addition, EGFR becomes fully activated after phosphorylation of Y845 by src family kinases. Phosphorylation of Y1045 leads to association with cbl and subsequent receptor degradation. Phosphorylation of S1047 by CamKinase II leads to attenuation of kinase activity, phosphorylation of T654 (by PKC) and T669 (by MAPK, p38) interferes with receptor endocytosis/recycling.Synonyms: EGF Receptor, Epidermal growth factor receptor, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, c-ErbB-1, erbB-1
-
ID gène
- 1956
-
UniProt
- P00533
-
Pathways
- Signalisation NF-kappaB, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Stem Cell Maintenance, Hepatitis C, Positive Regulation of Response to DNA Damage Stimulus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation, S100 Proteins
Antigène
-